Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review.
Behavioural theory
Pharmacy
Pharmacy research
Scoping review
Theoretical framework
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
04 Jan 2024
04 Jan 2024
Historique:
received:
20
08
2023
accepted:
16
11
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
4
1
2024
Statut:
aheadofprint
Résumé
Pharmacy practice research often focuses on the design, implementation and evaluation of pharmacy services and interventions. The use of behavioural theory in intervention research allows understanding of interventions' mechanisms of action and are more likely to result in effective and sustained interventions. To collate, summarise and categorise the reported behavioural frameworks, models and theories used in pharmacy practice research. PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science and EBSCO (CINAHL PLUS, British Education index, ERIC) were systematically searched to capture all pharmacy practice articles that had reported the use of behavioural frameworks, theories, or models since inception of the database. Results were filtered to include articles published in English in pharmacy practice journals. Full-text screening and data extraction were independently performed by two reviewers. A narrative synthesis of the data was adopted. Studies were reviewed for alignment to the UK Medical Research Council (MRC) framework to identify in which phase(s) of the research that the theory/model/framework had been employed. Fifty articles met the inclusion criteria; a trend indicating an increasing frequency of behavioural theory/frameworks/models within pharmacy practice research was identified; the most frequently reported were Theory of Planned Behaviour and Theoretical Domains Framework. Few studies provided explicit and comprehensive justification for adopting a specific theory/model/framework and description of how it underpinned the research was lacking. The majority were investigations exploring determinants of behaviours, or facilitators and barriers to implementing or delivering a wide range of pharmacy services and initiatives within a variety of clinical settings (aligned to Phase 1 UK MRC framework). This review serves as a useful resource for future researchers to inform their investigations. Greater emphasis to adopt a systematic approach in the reporting of the use of behavioural theories/models/frameworks will benefit pharmacy practice research and will support researchers in utilizing behavioural theories/models/framework in aspects of pharmacy practice research beyond intervention development.
Sections du résumé
BACKGROUND
BACKGROUND
Pharmacy practice research often focuses on the design, implementation and evaluation of pharmacy services and interventions. The use of behavioural theory in intervention research allows understanding of interventions' mechanisms of action and are more likely to result in effective and sustained interventions.
AIM
OBJECTIVE
To collate, summarise and categorise the reported behavioural frameworks, models and theories used in pharmacy practice research.
METHOD
METHODS
PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science and EBSCO (CINAHL PLUS, British Education index, ERIC) were systematically searched to capture all pharmacy practice articles that had reported the use of behavioural frameworks, theories, or models since inception of the database. Results were filtered to include articles published in English in pharmacy practice journals. Full-text screening and data extraction were independently performed by two reviewers. A narrative synthesis of the data was adopted. Studies were reviewed for alignment to the UK Medical Research Council (MRC) framework to identify in which phase(s) of the research that the theory/model/framework had been employed.
RESULTS
RESULTS
Fifty articles met the inclusion criteria; a trend indicating an increasing frequency of behavioural theory/frameworks/models within pharmacy practice research was identified; the most frequently reported were Theory of Planned Behaviour and Theoretical Domains Framework. Few studies provided explicit and comprehensive justification for adopting a specific theory/model/framework and description of how it underpinned the research was lacking. The majority were investigations exploring determinants of behaviours, or facilitators and barriers to implementing or delivering a wide range of pharmacy services and initiatives within a variety of clinical settings (aligned to Phase 1 UK MRC framework).
CONCLUSION
CONCLUSIONS
This review serves as a useful resource for future researchers to inform their investigations. Greater emphasis to adopt a systematic approach in the reporting of the use of behavioural theories/models/frameworks will benefit pharmacy practice research and will support researchers in utilizing behavioural theories/models/framework in aspects of pharmacy practice research beyond intervention development.
Identifiants
pubmed: 38175323
doi: 10.1007/s11096-023-01674-x
pii: 10.1007/s11096-023-01674-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Garcia-Cardenas V, Rossing CV, Fernandez-Llimos F, et al. Pharmacy practice research - a call to action. Res Social Adm Pharm. 2020;16(11):1602–8.
pubmed: 32919918
doi: 10.1016/j.sapharm.2020.07.031
Wiedenmayer K, Summers RS, Mackie CA, et al. Developing pharmacy practice: a focus on patient care: handbook. World Health Organization; 2006.
Fernandez-Llimos F, Desselle S, Stewart D, et al. Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada statements. Int J Clin Pharm. 2023;45:285-92.
pubmed: 36933233
Dreischulte T, van den Bemt B, Steurbaut S. European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper. Int J Clin Pharm. 2022;44(4):837–42.
pubmed: 35668277
pmcid: 9393137
doi: 10.1007/s11096-022-01422-7
Nosrgaard LS, Morgall JM, Bissell P. Arguments for theory-based pharmacy practice research. Int J Pharm Pract. 2011;8(2):77–81.
doi: 10.1111/j.2042-7174.2000.tb00989.x
Hemenway A, Meyer-Junco L, Zobeck B, et al. Utilizing social and behavioral change methods in clinical pharmacy initiatives. J Am Coll Clin Pharm. 2022;5(4):450-8.
doi: 10.1002/jac5.1593
Jamil N, Zainal ZA, Alias SH, et al. A systematic review of behaviour change techniques in pharmacist-delivered self-management interventions towards patients with chronic obstructive pulmonary disease. Res Soc Adm Pharm. 2023;19(8):1131–45.
doi: 10.1016/j.sapharm.2023.05.006
Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new medical research council guidance. BMJ. 2008;337: a1655.
pubmed: 18824488
pmcid: 2769032
doi: 10.1136/bmj.a1655
Michie S, Campbell R, Brown J, et al. ABC of theories of behaviour change. Great Britain: Silverback Publishing; 2014.
Scott J, Marshall G. A dictionary of sociology. Oxford: Oxford University Press; 2009.
doi: 10.1093/acref/9780199533008.001.0001
Wacker JG. A definition of theory: research guidelines for different theory-building research methods in operations management. J Oper Manag. 1998;16(4):361–85.
doi: 10.1016/S0272-6963(98)00019-9
Karnon J, Mackay M, Mills T, editors. Mathematical modelling in health care. In: 18th World IMACS/MODSIM Congress; 2009: Citeseer.
Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53.
pubmed: 25895742
pmcid: 4406164
doi: 10.1186/s13012-015-0242-0
Carpiano RM, Daley DM. A guide and glossary on post-positivist theory building for population health. J Epidemiol Community Health. 2006;60(7):564–70.
pubmed: 16790824
pmcid: 2566228
doi: 10.1136/jech.2004.031534
Creswell J, Creswell J. Research design: qualitative, quantitative, and mixed methods approaches. USA: Sage publications; 2017.
Hughes S, Davis TE, Imenda SN. Demystifying theoretical and conceptual frameworks: a guide for students and advisors of educational research. J Soc Sci. 2019;58(1–3):24–35.
Bandura A. Social cognitive theory of mass communication. Media Psychol. 2001;3(3):265–99.
doi: 10.1207/S1532785XMEP0303_03
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.
doi: 10.1016/0749-5978(91)90020-T
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.
pubmed: 10170434
doi: 10.4278/0890-1171-12.1.38
Michie S, Atkins L, West R. The behaviour change wheel A guide to designing interventions. 1st ed. London: Silverback Publishing; 2014.
Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.
pubmed: 22530986
pmcid: 3483008
doi: 10.1186/1748-5908-7-37
McGowan J, Straus S, Moher D, et al. Reporting scoping reviews-PRISMA ScR extension. J Clin Epidemiol. 2020;123:177–9.
pubmed: 32229248
doi: 10.1016/j.jclinepi.2020.03.016
Mendes AM, Tonin FS, Buzzi MF, et al. Mapping pharmacy journals: a lexicographic analysis. Res Social Adm Pharm. 2019;15(12):1464–71.
pubmed: 30683600
doi: 10.1016/j.sapharm.2019.01.011
Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
pubmed: 27919275
pmcid: 5139140
doi: 10.1186/s13643-016-0384-4
Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A Prod ESRC Methods Programme Version. 2006;1(1): b92.
Qudah B, Thakur T, Chewning B. Factors influencing patient participation in medication counseling at the community pharmacy: a systematic review. Res Soc Adm Pharm. 2021;17(11):1863–76.
doi: 10.1016/j.sapharm.2021.03.005
Alenezi A, Yahyouche A, Paudyal V. Roles, barriers and behavioral determinants related to community pharmacists’ involvement in optimizing opioid therapy for chronic pain: a qualitative study. Int J Clin Pharm. 2022;44(1):180–91.
pubmed: 34599720
doi: 10.1007/s11096-021-01331-1
Lindner N, Riesenhuber M, Müller-Uri T, et al. The role of community pharmacists in immunisation: a national cross-sectional study. Int J Clin Pharm. 2022;44(2):409–17.
pubmed: 34826016
doi: 10.1007/s11096-021-01357-5
Isenor JE, Minard LV, Stewart SA, et al. Identification of the relationship between barriers and facilitators of pharmacist prescribing and self-reported prescribing activity using the theoretical domains framework. Res Soc Adm Pharm. 2018;14(8):784–91.
doi: 10.1016/j.sapharm.2017.10.004
Gemmeke M, Koster ES, Rodijk EA, et al. Community pharmacists’ perceptions on providing fall prevention services: a mixed-methods study. Int J Clin Pharm. 2021;43(6):1533–45.
pubmed: 34121152
pmcid: 8642357
doi: 10.1007/s11096-021-01277-4
Patton DE, Ryan C, Hughes CM. Enhancing community pharmacists’ provision of medication adherence support to older adults: a mixed methods study using the theoretical domains framework. Res Soc Adm Pharm. 2021;17(2):406–18.
doi: 10.1016/j.sapharm.2020.03.004
Cardwell K, Hughes CM, Ryan C. Community pharmacists’ views of using a screening tool to structure medicines use reviews for older people: findings from qualitative interviews. Int J Clin Pharm. 2018;40(5):1086–95.
pubmed: 29796962
pmcid: 6208598
doi: 10.1007/s11096-018-0659-z
Bertilsson E, Serhal S, Emmerton L, et al. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial. Res Soc Adm Pharm. 2021;17(3):595–605.
doi: 10.1016/j.sapharm.2020.05.012
Alatawi YM, Kavookjian J, Ekong G, et al. The association between health beliefs and medication adherence among patients with type 2 diabetes. Res Soc Adm Pharm. 2016;12(6):914–25.
doi: 10.1016/j.sapharm.2015.11.006
Faisal S, Ivo J, Tennant R, et al. Implementation of a real-time medication intake monitoring technology intervention in community pharmacy settings: a mixed-method pilot study. Pharmacy (Basel). 2021;9(2).
Luke MJ, Krupetsky N, Liu H, et al. Pharmacists as personalized medicine experts (PRIME): experiences implementing pharmacist-led pharmacogenomic testing in primary care practices. Pharmacy (Basel). 2021;9(4).
Bright D, Worley M, Porter BL. Patient perceptions of pharmacogenomic testing in the community pharmacy setting. Res Soc Adm Pharm. 2021;17(4):744–9.
doi: 10.1016/j.sapharm.2020.06.022
Nichols MA, Arnett SJ, Fa B, et al. National survey identifying community pharmacist preceptors’ experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products. J Am Pharm Assoc. 2021;61(4s):S91-s104.
doi: 10.1016/j.japh.2021.01.016
Adeoye OA, Lake LM, Lourens SG, et al. What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management. J Am Pharm Assoc. 2018;58(4s):S7–15.
doi: 10.1016/j.japh.2018.03.001
Paudyal V, Gibson Smith K, MacLure K, et al. Perceived roles and barriers in caring for the people who are homeless: a survey of UK community pharmacists. Int J Clin Pharm. 2019;41(1):215–27.
pubmed: 30659491
pmcid: 6394502
doi: 10.1007/s11096-019-00789-4
Jonkman LJ, Tsuchihashi K, Liu E, et al. Patient experiences in managing non-communicable diseases in Namibia. Res Social Adm Pharm. 2020;16(11):1550–7.
pubmed: 32919919
doi: 10.1016/j.sapharm.2020.08.004
Okuyan B, Bektay MY, Demirci MY, et al. Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study. Int J Clin Pharm. 2022;44(1):247–55.
pubmed: 34761359
doi: 10.1007/s11096-021-01344-w
Kennelty KA, Chewning B, Wise M, et al. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists’ perspectives. Res Social Adm Pharm. 2015;11(4):517–30.
pubmed: 25586885
doi: 10.1016/j.sapharm.2014.10.008
Amin ME, Chewning B. Predicting pharmacists’ adjustment of medication regimens in Ramadan using the Theory of Planned Behavior. Res Social Adm Pharm. 2015;11(1):e1–15.
pubmed: 24908499
doi: 10.1016/j.sapharm.2014.04.004
Tan CL, Gan VB, Saleem F, et al. Building intentions with the Theory of Planned Behaviour: the mediating role of knowledge and expectations in implementing new pharmaceutical services in Malaysia. Pharm Pract (Granada). 2016;14(4):850.
pubmed: 28042358
doi: 10.18549/PharmPract.2016.04.850
Fleming ML, Bapat SS, Varisco TJ. Using the theory of planned behavior to investigate community pharmacists’ beliefs regarding engaging patients about prescription drug misuse. Res Soc Adm Pharm. 2019;15(8):992–9.
doi: 10.1016/j.sapharm.2018.10.027
Gülpınar G, Keleş Ş, Yalım NY. Perspectives of community pharmacists on conscientious objection to provide pharmacy services: a theory informed qualitative study. J Am Pharm Assoc. 2021;61(4):373-81.e1.
doi: 10.1016/j.japh.2021.03.014
Falope O, Vamos C, Izurieta R, et al. The knowledge and perceptions of Florida pharmacists in administering inactivated influenza vaccines to pregnant women. Pharmacy (Basel). 2021;9(2).
Hasan SA, Muzumdar JM, Nayak R, et al. Using the theory of planned behavior to understand factors influencing south Asian consumers' intention to seek pharmacist-provided medication therapy management services. Pharmacy (Basel). 2019;7(3).
Rushworth GF, Cunningham S, Pfleger S, et al. A cross-sectional survey of the access of older people in the Scottish Highlands to general medical practices, community pharmacies and prescription medicines. Res Soc Adm Pharm. 2018;14(1):76–85.
doi: 10.1016/j.sapharm.2017.01.002
Hattingh L, Sim TF, Sunderland B, et al. Successful implementation and provision of enhanced and extended pharmacy services. Res Soc Adm Pharm. 2020;16(4):464–74.
doi: 10.1016/j.sapharm.2019.06.015
Murad MS, Spiers JA, Guirguis LM. Expressing and negotiating face in community pharmacist-patient interactions. Res Soc Adm Pharm. 2017;13(6):1110–26.
doi: 10.1016/j.sapharm.2016.10.003
Wash A, Moczygemba LR, Anderson L, et al. Pharmacists’ intention to prescribe under new legislation. Res Soc Adm Pharm. 2022;18(5):2837–47.
doi: 10.1016/j.sapharm.2021.06.017
Seubert LJ, Kerry W, Laetitia H, et al. A theory based intervention to enhance information exchange during over-the-counter consultations in community pharmacy: a feasibility study. Pharmacy (Basel). 2019;7(2).
Seubert LJ, Whitelaw K, Hattingh L, et al. Development of a theory-based intervention to enhance information exchange during over-the-counter consultations in community pharmacy. Pharmacy (Basel). 2018;6(4).
Salgado TM, Moles R, Benrimoj SI, et al. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study. Int J Clin Pharm. 2012;34(4):569–78.
pubmed: 22538466
doi: 10.1007/s11096-012-9645-z
Amin MEK, Amine A, Newegy MS. Perspectives of pharmacy staff on dispensing subtherapeutic doses of antibiotics: a theory informed qualitative study. Int J Clin Pharm. 2017;39(5):1110–8.
pubmed: 28714040
doi: 10.1007/s11096-017-0510-y
Humphries B, Collins S, Guillaumie L, et al. Women's beliefs on early adherence to adjuvant endocrine therapy for breast cancer: a theory-based qualitative study to guide the development of community pharmacist interventions. Pharmacy (Basel). 2018;6(2).
George DL, Smith MJ, Draugalis JR, et al. Community pharmacists’ beliefs regarding improvement of star ratings scores using the theory of planned behavior. J Am Pharm Assoc. 2018;58(1):21–9.
doi: 10.1016/j.japh.2017.09.001
Ziaei Z, Hassell K, Schafheutle EI. Internationally trained pharmacists’ perception of their communication proficiency and their views on the impact on patient safety. Res Soc Adm Pharm. 2015;11(3):428–41.
doi: 10.1016/j.sapharm.2014.09.001
Chevalier BAM, Watson BM, Barras MA, et al. Hospital pharmacists’ and patients’ views about what constitutes effective communication between pharmacists and patients. Int J Pharm Pract. 2018;26(5):450–7.
pubmed: 29210472
doi: 10.1111/ijpp.12423
Amin ME, Chewning B. Pharmacists’ counseling on oral contraceptives: a theory informed analysis. Res Soc Adm Pharm. 2016;12(5):669–81.
doi: 10.1016/j.sapharm.2015.08.009
Lee SJ, Pincus KJ, Williams AA. Behavioral influences on prescription inhaler acquisition for persistent asthma in a patient-centered medical home. Res Soc Adm Pharm. 2016;12(5):789–93.
doi: 10.1016/j.sapharm.2015.11.007
Desai K, Chewning B, Mott D. Health care use amongst online buyers of medications and vitamins. Res Soc Adm Pharm. 2015;11(6):844–58.
doi: 10.1016/j.sapharm.2015.01.001
Hussein R, Whaley CRJ, Lin ECJ, et al. Identifying barriers, facilitators and behaviour change techniques to the adoption of the full scope of pharmacy practice among pharmacy professionals: using the theoretical domains framework. Res Soc Adm Pharm. 2021;17(8):1396–406.
doi: 10.1016/j.sapharm.2020.10.003
Mohammed E, Khanal S, Jalal Z, et al. Perceived barriers and facilitators to uptake of non-traditional roles by pharmacists in Saudi Arabia and implications for COVID-19 pandemic and beyond: a qualitative study using Theoretical Domain Framework. J Pharm Policy Pract. 2021;14(1):25.
pubmed: 33627172
pmcid: 7903212
doi: 10.1186/s40545-021-00307-w
Puspitasari HP, Costa DSJ, Aslani P, et al. An explanatory model of community pharmacists’ support in the secondary prevention of cardiovascular disease. Res Soc Adm Pharm. 2016;12(1):104–18.
doi: 10.1016/j.sapharm.2015.04.008
Pinto SL, Lively BT, Siganga W, et al. Using the Health Belief Model to test factors affecting patient retention in diabetes-related pharmaceutical care services. Res Soc Adm Pharm. 2006;2(1):38–58.
doi: 10.1016/j.sapharm.2005.11.001
Waddell J, Nissen L, Hale A. Advanced pharmacy practice in Australia and leadership: mapping the APPF against an evidence-based leadership framework. J Pharm Pract Res. 2017;47.
Demik DE, Vander Weg MW, Lundt ES, et al. Using theory to predict implementation of a physician-pharmacist collaborative intervention within a practice-based research network. Res Soc Adm Pharm. 2013;9(6):719–30.
doi: 10.1016/j.sapharm.2013.01.003
Odukoya OK, Stone JA, Chui MA. How do community pharmacies recover from e-prescription errors? Res Soc Adm Pharm. 2014;10(6):837–52.
doi: 10.1016/j.sapharm.2013.11.009
Fingleton N, Duncan E, Watson M, et al. Specialist clinicians' management of dependence on non-prescription medicines and barriers to treatment provision: an exploratory mixed methods study using behavioural theory. Pharmacy (Basel). 2019;7(1).
Luder H, Frede S, Kirby J, et al. Health beliefs describing patients enrolling in community pharmacy disease management programs. J Pharm Pract. 2016;29(4):374–81.
pubmed: 25609662
doi: 10.1177/0897190014566311
Viegas R, Godinho CA, Romano S. Physical activity promotion in community pharmacies: pharmacists’ attitudes and behaviours. Pharm Pract (Granada). 2021;19(3):2413.
pubmed: 34621452
doi: 10.18549/PharmPract.2021.3.2413
Abdu-Aguye SN, Mohammed S, Danjuma NM, et al. Improving outpatient medication counselling in hospital pharmacy settings: a behavioral analysis using the theoretical domains framework and behavior change wheel. Pharm Pract (Granada). 2021;19(2):2271.
pubmed: 34221193
doi: 10.18549/PharmPract.2021.2.2271
Luo M, Allman-Farinelli M. Trends in the number of behavioural theory-based healthy eating interventions inclusive of dietitians/nutritionists in 2000–2020. Nutrients. 2021;13(11):4161.
pubmed: 34836417
pmcid: 8623843
doi: 10.3390/nu13114161
Greene C, Wilson J. The use of behaviour change theory for infection prevention and control practices in healthcare settings: a scoping review. J Infect Prev. 2022;23(3):108–17.
pubmed: 35495101
pmcid: 9052851
doi: 10.1177/17571774211066779
Weston D, Ip A, Amlôt R. Examining the application of behaviour change theories in the context of infectious disease outbreaks and emergency response: a review of reviews. BMC Public Health. 2020;20(1):1483.
pubmed: 33004011
pmcid: 7528712
doi: 10.1186/s12889-020-09519-2
Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.
pubmed: 30178033
doi: 10.7326/M18-0850
Nili M, Mohamed R, Kelly KM. A systematic review of interventions using health behavioral theories to improve medication adherence among patients with hypertension. Transl Behav Med. 2020;10(5):1177–86.
pubmed: 33044533
doi: 10.1093/tbm/ibaa020
Imeri H, Toth J, Arnold A, et al. Use of the transtheoretical model in medication adherence: a systematic review. Res Soc Adm Pharm. 2022;18(5):2778–85.
doi: 10.1016/j.sapharm.2021.07.008
Power BT, Kiezebrink K, Allan JL, et al. Effects of workplace-based dietary and/or physical activity interventions for weight management targeting healthcare professionals: a systematic review of randomised controlled trials. BMC Obes. 2014;1:23.
pubmed: 26217510
pmcid: 4511014
doi: 10.1186/s40608-014-0023-3
Green J. The role of theory in evidence-based health promotion practice. Health Educ Res. 2000;15(2):125–9.
pubmed: 10751371
doi: 10.1093/her/15.2.125
Davidoff F, Batalden P, Stevens D, et al. Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Qual Saf Health Care. 2008;17(Suppl_1):i3–i9.
Corley KG, Gioia DA. Building theory about theory building: what constitutes a theoretical contribution? Acad Manag Rev. 2011;36(1):12–32.
doi: 10.5465/amr.2009.0486
Stewart D, Klein S. The use of theory in research. Int J Clin Pharm. 2016;38(3):615–9.
pubmed: 26511946
doi: 10.1007/s11096-015-0216-y
Long KM, McDermott F, Meadows GN. Being pragmatic about healthcare complexity: our experiences applying complexity theory and pragmatism to health services research. BMC Med. 2018;16(1):94.
pubmed: 29921277
pmcid: 6008915
doi: 10.1186/s12916-018-1087-6
Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348: g1687.
pubmed: 24609605
doi: 10.1136/bmj.g1687
Michie S, Prestwich A. Are interventions theory-based? Development of a theory coding scheme. Health Psychol. 2010;29(1):1–8.
pubmed: 20063930
doi: 10.1037/a0016939